Clinical trials in Eggenfelden

Groundbreaking clinical trials focusing on hormone receptor-positive (HR+) and HER2-negative early breast cancer treatments, evaluating innovative therapeutic approaches to prevent recurrence.

• Node-positive breast cancer treatments
• Extended endocrine therapy evaluation
• Adjuvant therapy optimization

Studies aim to enhance treatment outcomes through targeted therapeutic combinations.

Innovative research exploring the effectiveness of immunotherapy combinations with chemotherapy in treating aggressive forms of breast cancer.

• Neoadjuvant treatment approaches
• Chemotherapy optimization
• Novel drug combinations

Focus on improving survival rates through enhanced treatment protocols.

Comprehensive studies analyzing treatment patterns and therapeutic resistance in advanced breast cancer, with particular attention to first-line treatment strategies.

• Molecular pattern analysis
• Survival rate assessment
• Treatment resistance mechanisms

Research aims to improve long-term outcomes for patients with advanced disease.